HealthQuill Articles by: HealthQuill
Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and feed on, and hope the platform can help study the pattern of how the pathogens the insects carry impact and infect human cells and tissues.
Climate Health Medical

Brazil reels under dengue, public health emergency declared

HQ Team February 9, 2024: As millions descend in Rio De Janeiro in Brazil for the world-famous Carnival starting today, the government has

Read More
Global deaths due to COVID-19 have fallen by 95% since January, and nations need to take steps to manage virus variants alongside other infectious diseases, the WHO director-general said.
Drugs Health Medical

New research points at higher incidence of long COVID in children

HQ Team February 9, 2024: The coronavirus may have lost its virulence with time but its long-term effects are still being revealed among

Read More
About 152 million vulnerable babies were born too soon in the last decade ended 2020 and South Asian and Sub-Saharan regions accounted for more than 65% of preterm birth annually, the WHO stated. 
Climate Health Medical

Study links phthalate exposure to thousands of preterm births in US

HQ Team February 9, 2024: A comprehensive study has revealed a correlation between phthalate exposure and preterm births. Phthalates are chemical compounds used

Read More
Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to a statement from the University of Adelaide.
Drugs Health Pharma

A new oral drug may stop triple-negative breast cancer in its tracks

HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to

Read More
Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US regulatory body placed the experiments on full clinical hold, according to a company statement.
Drugs Health Pharma

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US

Read More
FDA has granted full approval for Janssen Biotech’s Balversa drug to treat metastatic bladder cancer after clinical trials showed “significant” improvement in overall survival rates.
Drugs Health Medical

Global cancer cases set to surge by 77% by 2050, new report warns

HQ Team February 6, 2024: A projection from the Global Cancer Observatory suggests that new cancer cases worldwide are set to surge by

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent

Read More
Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss firm access to a key drug for treating blood cancer.
Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss

Read More
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs Health Medical

Oral insulin successfully tested on animals, human trials set for 2025

Bharti Jayshankar February 5, 2024: Scientists have developed a form of oral insulin, offering an alternative to traditional syringes or insulin pumps. The

Read More
Eli Lilly, a US company that forecasts revenue of up to $33.9 billion, plans to build a $2.5 billion plant in Germany to make devices for treating diabetes and obesity.
Drugs Health Pharma

Novo Nordisk buys 3 Catalent sites for $11bn to meet rising demand for Wegovy

HQ Team February 5, 2024: Novo Nordisk will acquire three manufacturing sites in an $11bn deal to expand its production of weightless drugs

Read More